Our Autonomic Nervous System (ANS) device is FDA Cleared and Measures Arterial Stiffness, Vascularization and Endothelial Function.

Identify Heart Attack and Stroke Risks Early

Diabetic Cardiomyopathy is a disorder of the heart muscle in people with diabetes. It can lead to the inability of the heart to circulate blood through the body effectively, a state known as heart failure, with accumulation of fluid in the lungs (pulmonary edema) or legs (peripheral edema). Patients with diabetes Type 2 have up to a 74% increased risk of developing Heart Failure, and diabetic patients with HF are four times more likely to die than those without Heart Failure. Importantly, unrecognized Heart Failure is highly prevalent in Type 2 diabetics, with over one quarter (27.7%) of over 60's having previously undiagnosed Heart Failure in one report. Therefore it is one, if not the, most important assessment to be measured for all Type 2 diabetic patients.

Our test measures and graphs the heartbeat as it moves through systolic and diastolic during a 3-minutes screening to attain an overall cardiovascular assessment. The medical device uses a sophisticated algorithm to track variations that are not visible to the naked eye and interprets those results against a vast body of research.

Medical providers need to be made aware of the potential impact of cardiovascular conditions and complications in COVID-19 patients who require more intensive and frequent cardiovascular monitoring.

COVID-19 infection may cause a number of clinically significant cardiovascular events in connection with what is being called Post COVID Syndrome or Long COVID. COVID-19 infection may cause a number of clinically significant cardiovascular events in connection with what is being called Post-COVID Syndrome or Long COVID. An indirect effect is related to the delayed diagnosis of urgent non-COVID conditions, because of concern with going to a hospital. This has led to upticks in out-of-hospital heart attacks and strokes.1 

https://www.practicalpainmanagement.com/resources/practice-management/covid-19-long-haulers-look-cardiovascular-risk

The Only FDA Cleared Oral Device for Snoring and OSA

• FDA cleared to treat snoring, as well as mild to moderate obstructive sleep apnea (OSA).

• Fit in 15 minutes, allowing same-day treatment.

• Refit as many times as needed.

• Precision-Fit trays can be adjusted immediately for comfort.

• myTAP saves time for patients, dentists, and physicians since there is no need for a separate fitting appointment.

• The most effective device on the market, with over 45 peer-reviewed studies.

• Backed by our 30-day Patient Satisfaction Guarantee and 90-day Warranty.